Trial intelligence / Profile preview

Subcutaneous R744 in chronic renal failure patients with renal anemia

jRCT2080220015Phase 2

Sponsor
Chugai Pharmaceutical Co., Ltd.
Start
Sep 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of Carbon dioxide in chronic kidney disease (CKD) and anemia of renal disease, sponsored by Chugai Pharmaceutical Co., Ltd.

02

Drugs

Carbon dioxide
03

Conditions

chronic kidney disease (CKD)anemia of renal disease

Beyond the preview

Go deeper on jRCT2080220015.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080220015.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call